Cours IRRAS AB OTC Markets
Actions
IRRA.F
SE0008321202
Equipement, fournitures et distribution médicale
CA 2023 * | 165 M 15,55 M 14,04 M | CA 2024 * | 249 M 23,42 M 21,15 M | Capitalisation | 182 M 17,13 M 15,47 M |
---|---|---|---|---|---|
Résultat net 2023 * | -101 M -9,52 M -8,6 M | Résultat net 2024 * | -29 M -2,73 M -2,47 M | VE / CA 2023 * | 2,38 x |
Dette nette 2023 * | 211 M 19,86 M 17,93 M | Dette nette 2024 * | 258 M 24,3 M 21,94 M | VE / CA 2024 * | 1,77 x |
PER 2023 * |
-0,13
x | PER 2024 * |
-0,43
x | Employés | 47 |
Rendement 2023 * |
-
| Rendement 2024 * |
-
| Flottant | 3,55% |
Dernier transcript sur IRRAS AB
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Will Martin
CEO | Chief Executive Officer | 49 | 01/01/18 |
Griffen Stapp
DFI | Director of Finance/CFO | 38 | - |
Director/Board Member | 66 | 01/06/15 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marios Fotiadis
CHM | Chairman | 51 | 01/01/12 |
Director/Board Member | 66 | 01/06/15 | |
Director/Board Member | 69 | 01/09/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
+12,37% | 130 Md | |
-9,54% | 10,81 Md | |
-17,40% | 7,12 Md | |
+47,72% | 6,46 Md | |
-31,81% | 3,98 Md | |
+8,15% | 3,43 Md | |
-20,83% | 2,48 Md | |
-18,87% | 1,91 Md | |
-25,13% | 1,66 Md |